The Morning Brief

The Economic Times

To make sense of the week’s hottest stories in business, economy, politics and markets, journalists from the Economic Times chat with reporters and industry leaders in this thrice-weekly (Tuesday, Thursday, Friday) podcast. read less
NewsNews

Episodes

Everyone Wants a Piece of Ranjan Pai
4d ago
Everyone Wants a Piece of Ranjan Pai
Ranjan Pai, the head of the Manipal Education and Medical Group, has been quietly but aggressively backing tech unicorns in recent months. Firstcry, Bluestone, Purplle - the list goes on! He has also made a reappearance at troubled companies Pharmeasy and in a way in Byju’s through the latter’s acquired company Aakash Institute. So, what makes him such a sought-after investor? And how does someone who keeps such a low profile, beat aggressive investors to land the hottest deals? Know more about this billionaire doctor with an eye for tech. Tune in to the latest episode of The Morning Brief podcast hosted by Mugdha Variyar as she speaks to Mayank Ruia, Founder & Chief Executive Officer at MAIA Estates, Anirudh Pandita, Founder - Loco & Pocket Aces, Sunil Jain, Founder - Sprout Capital Advisors, Shailesh Ghorpade, Founding Managing Partner & CIO at Exfinity Venture Partners LLP, Archana Rai, Editor - South, The Economic Times, and Arijit Barman, Associate Editor, The Economic Times. Credits: ET NOW and CNBC-TV18 If you like this episode from Mugdha Variyar, check out her other interesting episodes on The IPO Bazaar: Should You Shop or Drop?, Explained: Why dark patterns are under the surveillance spotlight?, COP28: Another cop or another cop-out?, Idlis & Innovation with iD Fresh Food, ESOP Fables: Risks and Rewards and more!You can follow Mugdha Variyar on her social media: Twitter and Linkedin Catch the latest episode of ‘The Morning Brief’ on ET Play, The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Google Podcasts.See omnystudio.com/listener for privacy information.
India’s Breakthrough in Cancer Cure
5d ago
India’s Breakthrough in Cancer Cure
Thejna John is a happy woman. Last year, the relapse of an acute form of blood cancer despite a bone marrow transplant, had made her doctors give up all hope. In October, came a breakthrough. India approved the CAR T-Cell therapy, a revolutionary treatment for some forms of cancer. Thejna was one of the first cancer patients to undergo treatment in India. She is now cancer-free.   The potential of CAR T-cell therapy is significant. And Pharma majors from Dr Reddy’s to Biocon are pouring in money into their own CAR T-Cell projects. But it’s early days. And questions remain: on efficacy, relapse, neurotoxicity and high costs.    Join the conversation with host Anirban Chowdhury, Vikas Dandekar, ET's pharma expert, along with CAR T-Cell pioneer Dr. Hasmukh Jain, Associate Professor - Tata Memorial Centre, and Shirish Arya, Chief Business Officer - ImmunoACT as they discuss the future of this life-saving treatment on The Morning Brief podcast! Credits: TED If you like this episode from Anirban Chowdhury, check out his other interesting episodes on Fatigued & Flying: Why tired pilots are a wake-up call, Vizhinjam Port: Can Adani make India a global shipping hub?, Bhilai to Burj: The Rs. 5,000 Cr Bollywood Studded Mahadev Book Scam and more! You can follow Anirban Chowdhury on his social media: Twitter and Linkedin  Catch the latest episode of ‘The Morning Brief’ on ET Play, The Economic Times Online, Spotify, Apple Podcasts, Amazon Music and Google Podcasts. See omnystudio.com/listener for privacy information.